| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | +308.2% | |
| Gross profit | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.2) | −308.2% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 2.6 | 3.3 | 3.5 | 3.5 | 4.2 | 4.4 | +5.0% | |
| Selling & marketing | 2.5 | 3.3 | 3.5 | 3.5 | 0.0 | 0.0 | — | |
| Operating expenses | 2.6 | 3.3 | 3.5 | 3.5 | 4.2 | 4.2 | +0.3% | |
| Operating income | (2.6) | (3.3) | (3.5) | (3.5) | (4.3) | (4.4) | −3.8% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +231.1% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.2 | −13.3% | |
| Other income / expense | 0.1 | (0.2) | 0.8 | 0.0 | (0.2) | 0.5 | +357.7% | |
| Pre-tax income | (2.5) | (3.5) | (2.7) | (3.5) | (4.4) | (4.0) | +10.5% | |
| Income tax | 0.0 | (0.0) | 0.2 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (8.3) | (3.5) | (2.9) | (3.6) | (4.2) | (4.1) | +4.3% | |
| Discontinued operations | (5.8) | 0.0 | (0.2) | (0.2) | 0.2 | (0.1) | −155.9% | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.01) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | +23.8% | |
| EPS, diluted (per share) | (0.01) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | +23.8% | |
| EBITDA | (2.5) | (3.5) | (2.7) | (3.4) | (4.4) | (4.2) | +3.6% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | +308.2% | |
| Weighted average shares (shares) | 1,343,968,000 | 1,609,425,000 | 1,689,544,000 | 1,751,881,365 | 2,010,745,208 | 2,539,054,000 | +26.3% | |
| Weighted average diluted shares (shares) | 1,343,743,000 | 1,609,019,000 | 1,688,959,000 | 1,751,881,000 | 2,010,745,208 | 2,539,054,000 | +26.3% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
